Selected research
Market Structure
Global Organ Tumor Chip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Organ Tumor Chip market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Organ Tumor Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Organ Tumor Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Organ Tumor Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Organ Tumor Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Organ Tumor Chip include Axosim Technologies, Beonchip, BioIVT, Emulate, InSphero AG, Mimetas, Nortis and Organovo Holdings, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Organ Tumor Chip output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Organ Tumor Chip by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Organ Tumor Chip market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Organ Tumor Chip and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Organ Tumor Chip sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Organ Tumor Chip market size, projected growth trends, production technologies, key applications, and end-use industries.
Organ Tumor Chip Segment by Company
Axosim Technologies
Beonchip
BioIVT
Emulate
InSphero AG
Mimetas
Nortis
Organovo Holdings
Organ Tumor Chip Segment by Type
Lung Tumor-on-a-chip
Bone Marrow Tumor-on-a-chip
Brain Tumor-on-a-chip
Breast Tumor-on-a-chip
Urinary System Tumor-on-a-chip
Intestine Tumor-on-a-chip
Liver Tumor-on-a-chip
Organ Tumor Chip Segment by Application
Hospital
Laboratory
Organ Tumor Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Tumor Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ Tumor Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Tumor Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Organ Tumor Chip market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organ Tumor Chip industry.
Chapter 3: Detailed analysis of Organ Tumor Chip market competition landscape. Including Organ Tumor Chip manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Organ Tumor Chip by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Organ Tumor Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lung Tumor-on-a-chip
- Bone Marrow Tumor-on-a-chip
- Brain Tumor-on-a-chip
- Breast Tumor-on-a-chip
- Urinary System Tumor-on-a-chip
- Intestine Tumor-on-a-chip
- Liver Tumor-on-a-chip
Applications
- Hospital
- Laboratory
Companies covered
- Axosim Technologies
- Beonchip
- BioIVT
- Emulate
- InSphero AG
- Mimetas
- Nortis
- Organovo Holdings
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Organ Tumor Chip Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Organ Tumor Chip Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Organ Tumor Chip Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Organ Tumor Chip Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Organ Tumor Chip Market Dynamics
- 2.1 Organ Tumor Chip Industry Trends
- 2.2 Organ Tumor Chip Industry Drivers
- 2.3 Organ Tumor Chip Industry Opportunities and Challenges
- 2.4 Organ Tumor Chip Industry Restraints
3 Organ Tumor Chip Market by Manufacturers
- 3.1 Global Organ Tumor Chip Production Value by Manufacturers (2021-2026)
- 3.2 Global Organ Tumor Chip Production by Manufacturers (2021-2026)
- 3.3 Global Organ Tumor Chip Average Price by Manufacturers (2021-2026)
- 3.4 Global Organ Tumor Chip Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Organ Tumor Chip Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Organ Tumor Chip Manufacturers, Product Type & Application
- 3.7 Global Organ Tumor Chip Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Organ Tumor Chip Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Organ Tumor Chip Players Market Share by Production Value in 2025
- 3.8.3 2025 Organ Tumor Chip Tier 1, Tier 2, and Tier 3
4 Organ Tumor Chip Market by Type
- 4.1 Organ Tumor Chip Type Introduction
- 4.1.1 Lung Tumor-on-a-chip
- 4.1.2 Bone Marrow Tumor-on-a-chip
- 4.1.3 Brain Tumor-on-a-chip
- 4.1.4 Breast Tumor-on-a-chip
- 4.1.5 Urinary System Tumor-on-a-chip
- 4.1.6 Intestine Tumor-on-a-chip
- 4.1.7 Liver Tumor-on-a-chip
- 4.2 Global Organ Tumor Chip Production by Type
- 4.2.1 Global Organ Tumor Chip Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Organ Tumor Chip Production by Type (2021-2032)
- 4.2.3 Global Organ Tumor Chip Production Market Share by Type (2021-2032)
- 4.3 Global Organ Tumor Chip Production Value by Type
- 4.3.1 Global Organ Tumor Chip Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Organ Tumor Chip Production Value by Type (2021-2032)
- 4.3.3 Global Organ Tumor Chip Production Value Market Share by Type (2021-2032)
5 Organ Tumor Chip Market by Application
- 5.1 Organ Tumor Chip Application Introduction
- 5.1.1 Hospital
- 5.1.2 Laboratory
- 5.2 Global Organ Tumor Chip Production by Application
- 5.2.1 Global Organ Tumor Chip Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Organ Tumor Chip Production by Application (2021-2032)
- 5.2.3 Global Organ Tumor Chip Production Market Share by Application (2021-2032)
- 5.3 Global Organ Tumor Chip Production Value by Application
- 5.3.1 Global Organ Tumor Chip Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Organ Tumor Chip Production Value by Application (2021-2032)
- 5.3.3 Global Organ Tumor Chip Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Axosim Technologies
- 6.1.1 Axosim Technologies Company Information
- 6.1.2 Axosim Technologies Business Overview
- 6.1.3 Axosim Technologies Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.1.4 Axosim Technologies Organ Tumor Chip Product Portfolio
- 6.1.5 Axosim Technologies Recent Developments
- 6.2 Beonchip
- 6.2.1 Beonchip Company Information
- 6.2.2 Beonchip Business Overview
- 6.2.3 Beonchip Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.2.4 Beonchip Organ Tumor Chip Product Portfolio
- 6.2.5 Beonchip Recent Developments
- 6.3 BioIVT
- 6.3.1 BioIVT Company Information
- 6.3.2 BioIVT Business Overview
- 6.3.3 BioIVT Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.3.4 BioIVT Organ Tumor Chip Product Portfolio
- 6.3.5 BioIVT Recent Developments
- 6.4 Emulate
- 6.4.1 Emulate Company Information
- 6.4.2 Emulate Business Overview
- 6.4.3 Emulate Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.4.4 Emulate Organ Tumor Chip Product Portfolio
- 6.4.5 Emulate Recent Developments
- 6.5 InSphero AG
- 6.5.1 InSphero AG Company Information
- 6.5.2 InSphero AG Business Overview
- 6.5.3 InSphero AG Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.5.4 InSphero AG Organ Tumor Chip Product Portfolio
- 6.5.5 InSphero AG Recent Developments
- 6.6 Mimetas
- 6.6.1 Mimetas Company Information
- 6.6.2 Mimetas Business Overview
- 6.6.3 Mimetas Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.6.4 Mimetas Organ Tumor Chip Product Portfolio
- 6.6.5 Mimetas Recent Developments
- 6.7 Nortis
- 6.7.1 Nortis Company Information
- 6.7.2 Nortis Business Overview
- 6.7.3 Nortis Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.7.4 Nortis Organ Tumor Chip Product Portfolio
- 6.7.5 Nortis Recent Developments
- 6.8 Organovo Holdings
- 6.8.1 Organovo Holdings Company Information
- 6.8.2 Organovo Holdings Business Overview
- 6.8.3 Organovo Holdings Organ Tumor Chip Production, Value and Gross Margin (2021-2026)
- 6.8.4 Organovo Holdings Organ Tumor Chip Product Portfolio
- 6.8.5 Organovo Holdings Recent Developments
7 Global Organ Tumor Chip Production by Region
- 7.1 Global Organ Tumor Chip Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Organ Tumor Chip Production by Region (2021-2032)
- 7.2.1 Global Organ Tumor Chip Production by Region (2021-2026)
- 7.2.2 Global Organ Tumor Chip Production Forecast by Region (2027-2032)
- 7.3 Global Organ Tumor Chip Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Organ Tumor Chip Production Value by Region (2021-2032)
- 7.4.1 Global Organ Tumor Chip Production Value by Region (2021-2026)
- 7.4.2 Global Organ Tumor Chip Production Value by Region (2027-2032)
- 7.5 Global Organ Tumor Chip Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Organ Tumor Chip Production Value (2021-2032)
- 7.6.2 Europe Organ Tumor Chip Production Value (2021-2032)
- 7.6.3 Asia-Pacific Organ Tumor Chip Production Value (2021-2032)
- 7.6.4 South America Organ Tumor Chip Production Value (2021-2032)
- 7.6.5 Middle East & Africa Organ Tumor Chip Production Value (2021-2032)
8 Global Organ Tumor Chip Consumption by Region
- 8.1 Global Organ Tumor Chip Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Organ Tumor Chip Consumption by Region (2021-2032)
- 8.2.1 Global Organ Tumor Chip Consumption by Region (2021-2026)
- 8.2.2 Global Organ Tumor Chip Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Organ Tumor Chip Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Organ Tumor Chip Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Organ Tumor Chip Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Organ Tumor Chip Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Organ Tumor Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Organ Tumor Chip Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Organ Tumor Chip Value Chain Analysis
- 9.1.1 Organ Tumor Chip Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Organ Tumor Chip Production Mode & Process
- 9.2 Organ Tumor Chip Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Organ Tumor Chip Distributors
- 9.2.3 Organ Tumor Chip Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst